ME01157B - DERlVATI 6-HETEROCIKLIČNOG-IMIDAZO[1,2-a]PIRIDIN-2 -KARBOKSAMIDA, NJIHOVA PRIPREMA I NJIHOVA PRIMJENA U LIJEČENJU - Google Patents

DERlVATI 6-HETEROCIKLIČNOG-IMIDAZO[1,2-a]PIRIDIN-2 -KARBOKSAMIDA, NJIHOVA PRIPREMA I NJIHOVA PRIMJENA U LIJEČENJU

Info

Publication number
ME01157B
ME01157B MEP-2010-103A MEP10310A ME01157B ME 01157 B ME01157 B ME 01157B ME P10310 A MEP10310 A ME P10310A ME 01157 B ME01157 B ME 01157B
Authority
ME
Montenegro
Prior art keywords
group
pyrroine
carboxamides
imidazo
heterocyclic
Prior art date
Application number
MEP-2010-103A
Other languages
English (en)
Inventor
Jean-François Peyronel
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of ME01157B publication Critical patent/ME01157B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Pronalazak se odnosi na jedinjenja formule (I) u kojoj : X je opcionalno supstituisana fenil grupa; R 1  je atom vodonika, halogena, (C 1 -C 6 )alkoksi grupa, (C 1 -C 6 )alkil grupa, NR a R b , grupa; R 2  je opcionalno supstituisana heterociklična grupa; R 3  je atom vodonika, (C 1 -C 6 )alkil grupa, (C 1 -C 6 )alkoksi grupa ili halogen atom; R 4  je atom vodonika, (C 1 -C 4 )alkil grupa, (C 1 -C 4 )alkoksi grupa ili atom fluora; navedena jedinjenja su u obliku baze ili soli adicione soli kiseline. Ova jedinjenja se mogu koristiti u terapeutske svrhe.  
MEP-2010-103A 2008-01-02 2008-12-31 DERlVATI 6-HETEROCIKLIČNOG-IMIDAZO[1,2-a]PIRIDIN-2 -KARBOKSAMIDA, NJIHOVA PRIPREMA I NJIHOVA PRIMJENA U LIJEČENJU ME01157B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0800005A FR2925903B1 (fr) 2008-01-02 2008-01-02 DERIVES 6-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
PCT/FR2008/001836 WO2009106750A2 (fr) 2008-01-02 2008-12-31 Dérivés 6-heterocyclique-imidazo[1,2-a]pyrroine-2-carboxamides, leur préparation et leur application en thérapeutique

Publications (1)

Publication Number Publication Date
ME01157B true ME01157B (me) 2013-03-20

Family

ID=39745373

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2010-103A ME01157B (me) 2008-01-02 2008-12-31 DERlVATI 6-HETEROCIKLIČNOG-IMIDAZO[1,2-a]PIRIDIN-2 -KARBOKSAMIDA, NJIHOVA PRIPREMA I NJIHOVA PRIMJENA U LIJEČENJU

Country Status (25)

Country Link
US (2) US8314109B2 (me)
EP (1) EP2225240B1 (me)
JP (1) JP5258899B2 (me)
KR (1) KR101600635B1 (me)
CN (1) CN101959884B (me)
AR (1) AR070074A1 (me)
AU (1) AU2008351928B2 (me)
BR (1) BRPI0821458A2 (me)
CA (1) CA2710947C (me)
CL (1) CL2008003928A1 (me)
CO (1) CO6331309A2 (me)
EA (1) EA019122B1 (me)
FR (1) FR2925903B1 (me)
HK (1) HK1148016A1 (me)
IL (1) IL206669A (me)
MA (1) MA32527B1 (me)
ME (1) ME01157B (me)
MX (1) MX2010007353A (me)
MY (1) MY155468A (me)
NZ (1) NZ586474A (me)
SG (1) SG187408A1 (me)
TW (1) TWI432432B (me)
UY (1) UY31589A1 (me)
WO (1) WO2009106750A2 (me)
ZA (1) ZA201004644B (me)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925907B1 (fr) * 2008-01-02 2010-10-15 Sanofi Aventis DERIVES DE 2-HETEROAROYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
SG11201401359SA (en) * 2011-10-21 2014-05-29 Torrent Pharmaceuticals Ltd Novel substituted imidazopyrimidines as gpbar1 receptor modulators
EP2940002B1 (en) 2012-12-25 2016-12-14 Nippon Soda Co., Ltd. Halogenated aniline and method for producing same
CN108295074B (zh) * 2018-02-01 2020-08-28 华中农业大学 一种噻二唑并三嗪类化合物在制备单胺氧化酶抑制剂中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2638161B1 (fr) * 1988-10-24 1991-01-11 Centre Nat Rech Scient Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
IE904346A1 (en) * 1989-12-04 1991-06-05 Searle & Co IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF¹NEUROTOXIC INJURY
JP2006509497A (ja) * 2002-09-24 2006-03-23 ニューロ セラピューティクス エービー 神経発生に関する方法および物質
WO2004050659A1 (en) * 2002-11-27 2004-06-17 Eli Lilly And Company Novel compounds as pharmaceutical agents
WO2004103991A1 (fr) * 2003-05-20 2004-12-02 'chemical Diversity Research Institute', Ltd. Piperidines 2-substituees, bibliotheque focalisee et composition pharmaceutique
DE102005019181A1 (de) * 2005-04-25 2006-10-26 Novartis Ag Peptid-Deformylase (PDF) Inhibitoren 1
FR2903108B1 (fr) * 2006-07-03 2008-08-29 Sanofi Aventis Sa Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique.
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2903106B1 (fr) * 2006-07-03 2010-07-30 Sanofi Aventis Utilisations de 2-benzoyl-imidazopyridines en therapeutique

Also Published As

Publication number Publication date
MY155468A (en) 2015-10-15
IL206669A0 (en) 2010-12-30
US8314109B2 (en) 2012-11-20
KR20100109940A (ko) 2010-10-11
CO6331309A2 (es) 2011-10-20
JP2011508760A (ja) 2011-03-17
SG187408A1 (en) 2013-02-28
HK1148016A1 (me) 2011-08-26
FR2925903A1 (fr) 2009-07-03
BRPI0821458A2 (pt) 2015-06-16
EP2225240B1 (fr) 2014-01-22
AU2008351928B2 (en) 2013-11-21
NZ586474A (en) 2012-06-29
US20100317675A1 (en) 2010-12-16
CN101959884A (zh) 2011-01-26
EA201070814A1 (ru) 2011-02-28
WO2009106750A2 (fr) 2009-09-03
WO2009106750A3 (fr) 2010-02-25
CL2008003928A1 (es) 2010-02-12
US8691990B2 (en) 2014-04-08
AR070074A1 (es) 2010-03-10
EP2225240A2 (fr) 2010-09-08
CN101959884B (zh) 2013-02-27
MA32527B1 (fr) 2011-08-01
JP5258899B2 (ja) 2013-08-07
IL206669A (en) 2015-07-30
CA2710947A1 (fr) 2009-09-03
EA019122B1 (ru) 2014-01-30
UY31589A1 (es) 2009-08-03
FR2925903B1 (fr) 2011-01-21
TWI432432B (zh) 2014-04-01
TW200934780A (en) 2009-08-16
KR101600635B1 (ko) 2016-03-07
CA2710947C (fr) 2016-04-12
MX2010007353A (es) 2010-08-18
ZA201004644B (en) 2011-11-30
US20130041152A1 (en) 2013-02-14
AU2008351928A1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
ME00615B (me) DERIVATI 2-ARIL-6-FENIL-IMIDAZO[1,2-α]PIRIDINA, NJIHOVO DOBIJANJE I NJIHOVA TERAPEUTSKA PRIMjENA
EA201000113A1 (ru) Пиразольные соединения
RS53348B (en) PROCEDURE FOR THE PREPARATION OF 3-SUBSTITUTED 2-AMINO-5-HALOBENZAMIDES
RS52872B (en) PIRAL UNITS
CY1117324T1 (el) Παραγωγα 1-φαινυλ-2-πυριδινυλ αλκυλ αλκοολων ως αναστολεις φωσφοδιεστερασης
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
RS53627B1 (en) N- (3-Amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
EA200801996A1 (ru) 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов
RS53142B (en) UNITS THAT HAVE ANTAGONISTIC ACTIVITY ON CRTH2
EA200970207A1 (ru) Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов
PE20151951A1 (es) Heteroarildihidropirimidinas unidas por puentes en 6 para el tratamiento y la profilaxis de infeccion por el virus de la hepatitis b
EA201001683A1 (ru) Производные фенил- или пиридинилзамещенных индазолов
RS54183B1 (en) PIRAZOLE DERIVATIVES
WO2010089510A3 (fr) Dérivés d'azaspiranyl-alkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique
WO2010010288A3 (fr) Derives de carbamates d' alkylthiazoles, leur preparation et leur utilisation comme inhbiteurs de l'enzyme faah
CO6460742A2 (es) Derivados de ciclopenta[c]pirrolilalquilcarbamatos de heterociclos de 5 miembros, su preparación y su aplicación en terapéutica
RS54595B1 (en) 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
ME00957B (me) Derivati alkinil7-alkinil-1,8-naftirodoni, njihova priprema i primjena u liječenju
MX2016003422A (es) Imidazo[1,2-a]piridina-7-aminas como herramientas de imagen.
ME01157B (me) DERlVATI 6-HETEROCIKLIČNOG-IMIDAZO[1,2-a]PIRIDIN-2 -KARBOKSAMIDA, NJIHOVA PRIPREMA I NJIHOVA PRIMJENA U LIJEČENJU
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
EA201000604A1 (ru) Новые производные имидазола
NO20076161L (no) Fremgangsmater for fremstilling av 4-bifenylazetidin-2-oner
AR074629A1 (es) Derivados de 1-bencil-cinolin-4-(1h)-ona sustituidos, su preparacion, composiciones farmaceuticas y su uso en el tratamiento de patologias asociadas con receptores de los cannabinoides cb2
AR076205A1 (es) Derivados de 1-alquil-cinolin-4(1h)-ona, su preparacion, composicion farmaceutica y su uso para tratar patologias en la que esten implicados receptores de cannabinoides cb2